stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. SIGA
    stockgist
    HomeTop MoversCompaniesConcepts
    SIGA logo

    SIGA Technologies, Inc.

    SIGA
    NASDAQ
    Healthcare
    Drug Manufacturers - Specialty & Generic
    New York City, NY, US46 employeessiga.com
    $5.22
    +0.06(1.06%)

    Mkt Cap $374M

    $4.86
    $9.48

    52-Week Range

    At a Glance

    AI-generated

    SIGA Technologies, Inc.

    Revenue breakdown: Product Sales And Supportive Services (94.3%), Research And Development (5.7%).

    8-K
    SIGA Technologies, Inc. reported financial results for the three and twelve months ended December 31, 2025, with product sales of $88 million, total revenues of $94.6 million, operating income of $23.7 million, and net income of $23.3 million. The company received a $13 million international procurement order for oral TPOXX in January 2026 and secured $27 million in additional U.S. Government funding in 2025.

    $374M

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees46
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Product Sales And Supportive Services94.3%($704M)
    Research And Development5.7%($42M)

    Revenue by Geography

    US76.3%($323M)
    Non Us11.8%($50M)
    EMEA6.8%($29M)
    Asia Pacific3.5%($15M)
    CA1.5%($7M)
    Activity

    What Changed Recently

    Financial Results
    Mar 9, 2026

    , including the Press Release, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amen

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    OLMAOlema Pharmaceuticals, In...$15.11-0.10%$1.3B-7.9
    VTYXVentyx Biosciences, Inc.$14.00+0.00%$1.0B-9.4
    CTMXCytomX Therapeutics, Inc.$4.54-0.55%$772M-43.7
    ESPREsperion Therapeutics, In...$2.62+0.19%$544M-27.3
    RIGLRigel Pharmaceuticals, In...$27.56+0.22%$509M1.3
    EBSEmergent BioSolutions Inc...$8.20-2.15%$425M8.2
    AQSTAquestive Therapeutics, I...$4.14+0.24%$411M-5.7
    SNDLSNDL Inc.$1.36+2.26%$353M-31.2
    Analyst View
    Company Profile
    CIK0001010086
    ISINUS8269171067
    CUSIP826917106
    Phone212 672 9100
    Address31 East 62nd Street, New York City, NY, 10065, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice